PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING TO EVALUATE THE SYSTEMIC EXPOSURE OF GEFITINIB IN THE CYP2D6 ULTRARAPID METABOLIZERS AND EXTENSIVE METABOLIZERS.

被引：0
|
作者：
Chen, Y. [1 ]
Zhou, W. [1 ]
Tang, W. [1 ]
Zhou, D. [1 ]
Masson, E. [1 ]
机构：
[1] Astrazeneca, Waltham, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-021
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [41] CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline
    Alfaro, CL
    Lam, YWF
    Simpson, J
    Ereshefsky, L
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (02) : 155 - 163
  • [42] Low frequency of CYP2D6 poor metabolizers among schizophrenia patients
    LLerena, A.
    Dorado, P.
    Penas-LLedo, E. M.
    Caceres, M. C.
    De la Rubia, A.
    PHARMACOGENOMICS JOURNAL, 2007, 7 (06): : 408 - 410
  • [43] Increased heart rate response to metoprolol in CYP2D6 poor metabolizers
    Wuttke, H
    Rau, T
    Michels, L
    Bergmann, K
    Kreft, M
    Eschenhagen, T
    CIRCULATION, 2005, 112 (17) : U412 - U412
  • [44] CYP2D6 poor metabolizers in depressed women of Mexican origin.
    Flores, DL
    Flockhart, D
    Licinio, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P41 - P41
  • [45] Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers
    Begré, S
    von Bardeleben, U
    Ladewig, D
    Jaquet-Rochat, S
    Cosendai-Savary, L
    Golay, KP
    Kosel, M
    Baumann, P
    Eap, CB
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 211 - 215
  • [46] DNA HAPLOTYPE DEPENDENCY OF DEBRISOQUINE 4-HYDROXYLASE (CYP2D6) EXPRESSION AMONG EXTENSIVE METABOLIZERS
    MURA, C
    PANSERAT, S
    VINCENTVIRY, M
    GALTEAU, MM
    JACQZAIGRAIN, E
    KRISHNAMOORTHY, R
    HUMAN GENETICS, 1993, 92 (04) : 367 - 372
  • [47] Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers
    Loghin, Corina
    Haber, Harry
    Beasley, Charles M., Jr.
    Kothare, Prajakti A.
    Kauffman, Lynnette
    April, John
    Jin, Ling
    Allen, Albert J.
    Mitchell, Malcolm I.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (02) : 549 - 560
  • [48] EFFECT OF PF299804 ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS (HVS) WHO ARE EXTENSIVE METABOLIZERS (EM)
    Bello, C. L.
    Labadie, R. R.
    Ni, G.
    Boutros, T.
    McCormick, C.
    Ndongo, N.
    ANNALS OF ONCOLOGY, 2010, 21 : 178 - 178
  • [49] The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers
    Bello, Carlo L.
    LaBadie, Robert R.
    Ni, Grace
    Boutros, Tanya
    McCormick, Carol
    Ndongo, M. Noella
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 991 - 997
  • [50] The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers
    Carlo L. Bello
    Robert R. LaBadie
    Grace Ni
    Tanya Boutros
    Carol McCormick
    M. Noella Ndongo
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 991 - 997
12345